Seastar Medical Is A Commercial Stage Medical Technology Company Based In Denvercoloradofocused On Developing Extracorporeal Therapies To Combat Excessive Inflammation In Critically Ill Patientsincorporated In 2020The Company Aims To Improve Patient Outcomes By Transforming Immune Responses Or Removing Harmful Cytokines That Contribute To Organ Failure The Flagship Productthe Selective Cytopheretic Devicescd Is Designed To Neutralize Overactive Immune Cells And Halt Cytokine Stormswhich Can Lead To Severe Hyperinflammationseastar Medical Also Offers Quelimmunescd Ped The First Fda Approved Treatment For Life Threatening Acute Kidney Injury In Critically Ill Pediatric Patientsthe Company Has Received Breakthrough Device Designation For Multiple Therapeutic Indicationsfacilitating A Faster Approval Process Led By A Team Of Experienced Professionalsincluding Critical Care Physiciansseastar Medical Targets Critical Care Clinicians And Hospitalsproviding Innovative Solutions For Managing Severe Inflammatory Conditions
